Category Archives: Actualidad

NTU scientist develops a multi-purpose wonder material to tackle environmental challenges

Science fiction? Hardly, and there’s more – It can also desalinate water, be used as flexible water filtration membranes, help recover energy from desalination waste brine, be made into flexible solar cells and can also double the lifespan of lithium ion batteries. With its superior bacteria-killing capabilities, it can also be used to develop a… Continue reading

Primera vacuna contra la cistitis: una iniciativa público-privada


La cistitis recurrente es una infección del tracto urinario con gran prevalencia y de especial incidencia entre las mujeres. Este proyecto conjunto de las Universidades de Vigo y de Santiago, la spin-off Nanoimmunotech y las empresas CZ Veterinaria-Biofabri y Nanogap tiene como objetivo el desarrollo de la primera vacuna a nivel mundial para esta enfermedad. La iniciativa cuenta con tres millones de euros y el apoyo del programa Feder-Innterconecta del CDTI.


Continue reading

Targeted delivery of a decoy oligodeoxynucleotide to a single ES cell by femtoinjection – Corrected Proof

Abstract: Femtoinjection has been proposed as a feasible approach for the targeted delivery of a decoy oligodeoxynucleotide (ODN) into a single ES cell for the study of transcription factor activity. Here, we evaluated the utility of decoy ODN delivery via femtoinjection in an ES cell model in which Venus fluorescent protein was expressed under… Continue reading

Highly sensitive localized surface plasmon resonance immunosensor for label-free detection of HIV-1 – Corrected Proof

Abstract: A highly sensitive label-free immunosensor for the detection of HIV-1 is newly developed based on localized surface plasmon resonance (LSPR) method. Uniform nanopattern of circular Au-dots (10-20nm) was fabricated on indium tin oxide (ITO) coated glass substrate by simple electrochemical deposition method. The surface of Au nanopattern… Continue reading

Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies – Corrected Proof

Abstract: Dendritic cells (DC), which play a major role in development of cell-mediated immunity, represent opportunities to develop novel anti-HIV vaccines. Dendrimers have been proposed as new carriers to ameliorate DC antigen loading and in this way, we have determined the potential use of maltose decorated neutrally and positively charged G4… Continue reading